Dosidal · Switzerland
Zoledronat Onco Labatec 4 mg/5 ml, solution à diluer pour perfusion
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:63012 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 63012 atc: M05BA08 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2013-04-16 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: M05BA08 authorisation_number: 63012 form: KOINF holder: Labatec Pharma SA holder_partner_nr: 1000310 it_number: 07.99.0. name: Zoledronat Onco Labatec 4 mg/5 ml, solution à diluer pour perfusion state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53W3z1t7jCF2fAHz6__B7y0DKMikR5Q6uI8HT5IRfn5IIzfz5RsuNl1zKZW5pqJ-Jw5SJ9P03MmpvPXfpt9_kRlwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ch:authorisation:63012 · Related records in other markets · Dosidal